These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 6705899)
61. [Importance of the metabolic oxidation of drugs and other xenobiotics: recent developments]. Fleury MB Ann Pharm Fr; 2011 Jan; 69(1):1-2. PubMed ID: 21296211 [No Abstract] [Full Text] [Related]
62. Some aspects of the in vitro oxidation of 35S-chlorpromazine. Gorrod JW; Lazarus CR; Beckett AH Adv Biochem Psychopharmacol; 1974; 9(0):191-200. PubMed ID: 4836203 [No Abstract] [Full Text] [Related]
63. [Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs]. Ackermann E Pharmazie; 1978 Jul; 33(7):400-6. PubMed ID: 364493 [No Abstract] [Full Text] [Related]
64. Cytochrome P450 metabolism and inhibition: analysis for drug discovery. Jones BC; Middleton DS; Youdim K Prog Med Chem; 2009; 47():239-63. PubMed ID: 19328293 [No Abstract] [Full Text] [Related]
66. Duration of drug interactions: putative time courses after mechanism-based inhibition or induction of CYPs. Imai H; Kotegawa T; Ohashi K Expert Rev Clin Pharmacol; 2011 Jul; 4(4):409-11. PubMed ID: 22114850 [No Abstract] [Full Text] [Related]
67. Drugs and the ageing liver. James OF J Hepatol; 1985; 1(4):431-5. PubMed ID: 3902953 [No Abstract] [Full Text] [Related]
68. Reductive drug metabolism. Mc Lane KE; Fisher J; Ramakrishnan K Drug Metab Rev; 1983; 14(4):741-99. PubMed ID: 6352224 [No Abstract] [Full Text] [Related]
69. [Relationship between nutritional status and drug metabolism in man]. PuzyĆska L Pol Tyg Lek; 1978 Aug; 33(35):1387-90. PubMed ID: 714765 [No Abstract] [Full Text] [Related]
70. [The behavioral dynamics and catalytic properties of the cytochrome P-450 of liver microsomes in the presence of Mg2+ ions]. Kiselev PA; Garda G; Finch SA; Stier A; Gurinovich NA Dokl Akad Nauk SSSR; 1989; 309(4):984-7. PubMed ID: 2635670 [No Abstract] [Full Text] [Related]
71. Cytochrome P-450s: research highlights of the last two decades. Alvares AP Drug Metab Rev; 1981; 12(2):431-6. PubMed ID: 7040021 [No Abstract] [Full Text] [Related]
72. Proceedings: Drug metabolism in the human liver measured with in vitro and in vivo methods. Remmer H Arzneimittelforschung; 1976; 26(6):1262-3. PubMed ID: 989459 [No Abstract] [Full Text] [Related]
73. Effects of induction of cytochrome P-450 enzymes on the concentration of foreign compounds and their metabolites and on the toxicological effects of these compounds. Gillette JR Drug Metab Rev; 1979; 10(1):59-87. PubMed ID: 118860 [TBL] [Abstract][Full Text] [Related]
78. Enzymatic activity and biotransformation of anesthetics. Brown BR Int Anesthesiol Clin; 1974; 12(2):25-34. PubMed ID: 4603050 [No Abstract] [Full Text] [Related]
79. Effect of various potential inhibitors, activators and inducers on the N-oxidation of isomeric aromatic diazines in vitro using rabbit liver microsomal preparations. Altuntas TG; Gorrod JW Xenobiotica; 1996 Jan; 26(1):9-15. PubMed ID: 8851817 [TBL] [Abstract][Full Text] [Related]